McKesson Pays $82M To End Drug Price Inflation Suit

Law360, New York (October 27, 2011, 4:33 PM ET) -- McKesson Corp. on Wednesday agreed to pay $82 million to resolve a Massachusetts class action brought by several municipalities accusing the pharmaceutical distributor of scheming to fraudulently inflate prices of more than 400 brand-name prescription drugs, including Prozac, Lipitor, Zocor and Vioxx.

The states of Oklahoma and Montana; the cities of Baltimore, Columbia, S.C., Panama City, Fla., and Goldsboro, N.C.; Anoka County, Minn.; and the board of county commissioners of Douglas County, Kan., launched the suit in August 2008 on behalf of cities, counties and other...
To view the full article, register now.